Driehaus Capital Management LLC Makes New Investment in Oaktree Acquisition Corp. III Life Sciences $OACC

Key Points

• Driehaus Capital Management LLC has made a new investment of approximately $9.18 million in Oaktree Acquisition Corp. III Life Sciences by acquiring 900,000 shares, resulting in a 4.01% ownership stake.
• Additional institutional investors, including high-profile firms like Kepos Capital LP and Mizuho Securities USA LLC, have also established new positions in Oaktree Acquisition Corp. III Life Sciences during the first quarter.
• The stock price of Oaktree Acquisition Corp. III Life Sciences is currently trending upward, opening at $10.46 with a 52-week range between $9.95 and $10.85.

Driehaus Capital Management LLC purchased a new stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 900,000 shares of the company's stock, valued at approximately $9,180,000. Driehaus Capital Management LLC owned 4.01% of Oaktree Acquisition Corp. III Life Sciences as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Kepos Capital LP acquired a new stake in Oaktree Acquisition Corp. III Life Sciences during the 1st quarter valued at $563,000. Picton Mahoney Asset Management purchased a new stake in Oaktree Acquisition Corp. III Life Sciences in the 1st quarter worth about $767,000. HighTower Advisors LLC acquired a new stake in Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth about $1,401,000. K2 Principal Fund L.P. purchased a new position in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at about $1,945,000. Finally, Mizuho Securities USA LLC acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the 1st quarter valued at about $2,020,000.

Oaktree Acquisition Corp. III Life Sciences Stock Performance

OACC traded up $0.01 on Thursday, reaching $10.45. 266,028 shares of the company traded hands, compared to its average volume of 82,838. The stock's 50 day moving average price is $10.44 and its 200-day moving average price is $10.33. Oaktree Acquisition Corp. III Life Sciences has a 52-week low of $9.95 and a 52-week high of $10.85.

Oaktree Acquisition Corp. III Life Sciences Profile

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.